PacBio Named Senior Party in USPTO Interference Involving VisiGen Patent | GenomeWeb

This article has been updated from a previous version to include comment from Pacific Biosciences.

Pacific Biosciences said last week that it has been named the senior party in an ongoing US Patent and Trademark Office interference that involves a patent held by Life Technologies and a patent application filed by PacBio that both cover single-molecule sequencing technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.